Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

Schnog, J. B.; Teerlink, T.; van der Dijs, F. P. L.; Duits, A. J.; Muskiet, F. A. J.; CURAMA Study Group
May 2005
Annals of Hematology;May2005, Vol. 84 Issue 5, p282
Academic Journal
journal article
In recent years an important role has been ascribed to a reduced nitric oxide (NO) availability in the pathophysiology of sickle cell disease (SCD). Endogenously produced inhibitors of NO synthase, in particular asymmetric dimethylarginine (ADMA), are currently considered of importance in various vascular disease states characterized by reduced NO availability. We determined ADMA levels in plasma of 12 adult sickle cell patients (eight HbSS and four HbSC), and compared these to plasma levels in race- and age-matched controls. Sickle cell patients were characterized by strongly elevated levels of ADMA [HbSS: median 0.63 micromol/l (interquartile range 0.54-0.85), HbSC: 0.43 micromol/l (0.40-0.46), HbAA: 0.33 micromol/l (0.32-0.35) p<0.001]. ADMA levels were highest in HbSS patients with lowest hemoglobin levels and highest leukocyte counts, and in HbSS patients ADMA levels were positively associated with serum levels of soluble vascular cell adhesion molecule-1. These results suggest an important role of ADMA in limiting NO availability in SCD, and its role in the pathophysiology of SCD should be further investigated.


Related Articles

  • β-Globin Gene Cluster Haplotype Analysis as a Predictor of Sickle Cell Disease Severity. Henry Ogedegbe // Laboratory Medicine;Sep2007, Vol. 38 Issue 9, p563 

    The origin of sickle cell disease has been traced to Africa and is due to a genetic mutation in the β-globin gene. Factors contributing to the variance in disease severity include levels of fetal hemoglobin, the presence of α-thalassemia, and the type of hemoglobin haplotype linked...

  • Cognitive Deficits in Children With Sickle Cell Disease. Steen, R. Grant; Fineberg-Buchner, Charlotte; Hankins, Gisele; Weiss, Larry; Prifitera, Aurelio; Mulhern, Raymond K. // Journal of Child Neurology;Feb2005, Vol. 20 Issue 2, p102 

    We tested a hypothesis that children with sickle cell disease who are completely normal by magnetic resonance imaging can still be cognitively impaired, as predicted by a model of diffuse brain injury. Fifty-four patients with hemoglobin SS (average age 10.9 years ± 2.9 years SD) were...

  • Anemia de células falciformes con persistencia de hemoglobina fetal como factor protector: reporte de caso. Rivera-Paz, Edward E.; Palencia, Eleonora Paulette; Espinal-Palacios, Ana Gabriela; Peña-Hernández, Armando // Revista Mexicana de Pediatria;2016, Vol. 83 Issue 2, p55 

    Sickle cell anemia is an autosomal recessive genetic disease characterized by the presence of hemoglobin sickle in erythrocytes. A mutation in the sixth codon of the gene for β-globin causes an abnormal hemoglobin synthesis or hemoglobin sickle. In children, the acute complications are severe...

  • Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. Williams, Thomas N.; Mwangi, Tabitha W.; Wambua, Sammy; Alexander, Neal D.; Kortok, Moses; Snow, Robert W.; Marsh, Kevin // Journal of Infectious Diseases;7/1/2005, Vol. 192 Issue 1, p178 

    Background: The gene for sickle hemoglobin (HbS) is a prime example of natural selection. It is generally believed that its current prevalence in many tropical populations reflects selection for the carrier form (sickle cell trait [HbAS]) through a survival advantage against death...

  • Call for national sickle cell database.  // British Journal of Hospital Medicine (17508460);Jun2008, Vol. 69 Issue 6, p317 

    The article reports that the British National Confidential Enquiry into Patient Outcome and Death (NCEPOD) has indicated that the serious complications of sickle cell disease that may ultimately lead to death are not well known. The NCEPOD has released the results of the first national survey on...

  • The Facts About Sickle Cell Disease.  // Ebony;Jul2006, Vol. 61 Issue 9, p70 

    Presents an interview with Dr. Willarda Edwards, president and chief operating officer of Sickle Cell Disease Association of America Inc. about sickle cell disease. Definition of sickle cell disease; Transmission of and risk factors for the development of sickle cell disease; Treatment of the...

  • When Your Child Has Sickle Cell Disease.  // American Family Physician;7/15/2006, Vol. 74 Issue 2, p313 

    The article presents information on sickle cell disease in children. It is a type of blood disease inherited by children from their parents. Children with sickle cell disease are at risk to have serious infection and severe anemia. To lower the chances of children with sickle cell disease to get...

  • Chapter 8: The Normochromic Anemias Caused by Hemoglobinopathies. Ciesla, Betty // Hematology in Practice;2007, p113 

    Chapter 8 of the book "Hematology in Practice" is presented. It discusses the characteristics of the hemoglobinopathies. The pathophysiology and the amino acid substitution in sickle cell disorders are described, as well as the inheritance patterns of the disorders. It also differentiates the...

  • Ischaemic cholangiopathy and sickle cell disease. Ahmed, Mansoor; Dick, Moira; Mieli-Vergani, Giorgina; Harrison, Phil; Karani, John; Dhawan, Anil // European Journal of Pediatrics;Feb2006, Vol. 165 Issue 2, p112 

    We report a case of a 6-year-old girl of Afro-Caribbean origin, known to have sickle cell disease (SCD), with recurrent history of jaundice and abdominal pain. She was extensively investigated, including endoscopic retrograde cholangiopancreatography (ERCP), which revealed diffuse cholangiopathy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics